Myelosuppression with Oxazolidinones: Are There Differences?
Antimicrob Agents Chemother
.
2018 Dec 21;63(1):e01833-18.
doi: 10.1128/AAC.01833-18.
Print 2019 Jan.
Authors
Cathy Hardalo
1
,
Thomas P Lodise
2
,
Carisa De Anda
3
Affiliations
1
Merck & Co., Inc., Kenilworth, New Jersey, USA
[email protected]
.
2
Albany College of Pharmacy and Health Sciences, Albany, New York, USA.
3
Merck & Co., Inc., Kenilworth, New Jersey, USA.
PMID:
30578404
PMCID:
PMC6325221
DOI:
10.1128/AAC.01833-18
No abstract available
Keywords:
myelosuppression; oxazolidinones.
Publication types
Letter
Comment
MeSH terms
Humans
Linezolid
Oxazolidinones*
Thrombocytopenia*
Substances
Oxazolidinones
Linezolid